Name: TIDES: Oligonucleotide and Peptide Therapeutics 2019
Start: 2019-05-20
End: 2019-05-23
Location: Manchester Grand Hyatt San Diego

OVERVIEW

TIDES: Oligonucleotide and Peptide Therapeutics is organized by KNect365 Life Sciences and will be held from May 20 - 23, 2019 at Manchester Grand Hyatt San Diego, San Diego, California, United States of America.

TIDES offers the science, technologies and partners you need to grow your business

• 1000+ Oligonucleotide and Peptide Scientists and Executives
Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.

• 90+ Exhibitors
Connect with leading manufacturing, technologies, and service providers to drive your promising therapeutic towards commercial success.

• 125+ Case Studies and New Data Presentations
Hear best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.

Conference Description:
TIDES offers separate tracks covering the latest oligonucleotide and peptide development strategies from discovery, nonclinical, clinical and CMC to late-stage development and commercialization.

Oligonucleotide Tracks:
• Chemistry, Manufacturing & Controls:Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.
• Discovery, Preclinical and Clinical: Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Tracks:
• Chemistry, Manufacturing & Controls: Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.
• Discovery, Preclinical and Clinical: Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

Time: 9:00 am - 5:00 pm

Speakers: Kevin Fitzgerald, Alnylam Pharmaceuticals, Sarah Boyce, Akcea Therapeutics, Stanley Crooke, Ionis Pharmaceuticals, Bradley Pentelute, Massachusetts Institute of Technology

Additional details will be posted as soon as they are available.